SARS-CoV-2 Spike receptor binding domain, RBD (319-335) -Lys(Biotin-LC) – 0.1 mg

Overview

The SARS-CoV-2 Spike receptor binding domain (RBD) peptide, spanning residues 319-335, is critical for understanding the virus’s entry mechanism into host cells. This specific sequence, derived from the spike protein of SARS-CoV-2, has been meticulously designed with a Biotin-LC label at the C-terminus, facilitating easy detection and binding in various assays. Whether you are conducting research on viral interactions, developing diagnostic tools, or studying vaccine responses, this peptide is an essential component of your experimental toolkit.

Key Features

• Biotin-LC labeled RBD peptide for enhanced assay performance
• C-terminal biotin tag allows for straightforward detection
• Supports research on SARS-CoV-2 interactions and vaccine development
• Purity grade suitable for research and diagnostic applications
• Available in a 0.1 mg package for convenient use

Specifications

FAQ

What applications can I use this peptide for?

This SARS-CoV-2 Spike RBD peptide is ideal for assays related to viral studies, including binding assays, ELISAs, and other detection methods where receptor interactions are examined.

How should I store this peptide?

To maintain stability, store this peptide at -20°C. Avoid repeated freeze-thaw cycles to preserve its integrity.

Is this peptide suitable for in vivo studies?

While this peptide is primarily designed for in vitro applications, its use in vivo should be evaluated based on the specific experimental conditions and safety assessments.

If you are looking to enhance your research capabilities, consider pairing this peptide with our PKG Substrate or exploring our range of other peptides for diverse applications. For advanced studies, check our Autocamtide-2 for additional enzymatic assays. Don’t miss out on the opportunity to use this essential peptide in your research!

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled